<p>阿卡迪亞醫療保健公司（NASDAQ:ACHC - 獲取免費報告）目前被 16 位分析師給予了 “持有” 的平均推薦，MarketBeat Ratings 報告稱。兩位投資分析師對該股票給予了賣出評級，六位分析師給予了持有評級，八位分析師給予了買入評級。在過去一年中，發佈報告的券商對該股票的平均一年目標價為 23.1667 美元。</p>
<p>獲取 <strong>阿卡迪亞醫療保健</strong> 的提醒：</p>
<ul>
<li>Neurogene 股票暴跌 44%：這家生物科技公司還有希望嗎？</li>
</ul>
<p>幾位股票分析師最近對該公司發佈了報告。KeyCorp 將阿卡迪亞醫療保健的目標價從 30.00 美元下調至 25.00 美元，並在 12 月 3 日的研究報告中給予該股票 “增持” 評級。加拿大皇家銀行將阿卡迪亞醫療保健的目標價從 22.00 美元下調至 19.00 美元，並在 12 月 3 日的研究報告中給予該股票 “跑贏大盤” 評級。Leerink Partners 將阿卡迪亞醫療保健的股票評級從 “強力買入” 下調至 “持有”，該報告於 12 月 3 日發佈。瑞銀集團將阿卡迪亞醫療保健的目標價從 28.00 美元下調至 24.00 美元，並在 12 月 3 日的研究報告中給予該股票 “買入” 評級。最後，Raymond James Financial 在 12 月 3 日的研究報告中設定了阿卡迪亞醫療保健的目標價為 17.00 美元。</p>
<p><strong>閲讀我們關於 ACHC 的最新報告</strong></p>
<h2>機構資金流入和流出</h2>
<p>一些機構投資者最近增加或減少了對 ACHC 的持股。凱通國際資產管理有限公司在第一季度將其在阿卡迪亞醫療保健的持股增加了 11218.2%。凱通國際資產管理有限公司現在擁有 1245 股該公司的股票，價值 38,000 美元，此前在上個季度購買了 1234 股。Allworth Financial LP 在第二季度將其在阿卡迪亞醫療保健的持股增加了 676.4%。Allworth Financial LP 現在擁有 1351 股該公司的股票，價值 31,000 美元，此前在此期間又收購了 1177 股。EverSource Wealth Advisors LLC 在第二季度將其在阿卡迪亞醫療保健的持股增加了 54.8%。EverSource Wealth Advisors LLC 現在擁有 1404 股該公司的股票，價值 32,000 美元，此前在上個季度購買了 497 股。Hantz Financial Services Inc. 在第三季度將其在阿卡迪亞醫療保健的持股增加了 501.9%。Hantz Financial Services Inc. 現在擁有 2185 股該公司的股票，價值 54,000 美元，此前在此期間又購買了 1822 股。最後，Covestor Ltd 在第一季度將其在阿卡迪亞醫療保健的持股增加了 56.0%。Covestor Ltd 現在擁有 2262 股該公司的股票，價值 69,000 美元，此前在上個季度購買了 812 股。</p>
<h2>阿卡迪亞醫療保健股票表現</h2>
<p>ACHC 股票在週五開盤價為 14.45 美元。該股票的市值為 13.3 億美元，市盈率為 12.35，PEG 比率為 3.24，貝塔值為 0.91。阿卡迪亞醫療保健的年內最低價為 12.63 美元，最高價為 47.08 美元。該公司的 50 日簡單移動平均線為 19.79 美元，200 日簡單移動平均線為 21.46 美元。該公司的債務與股本比率為 0.73，速動比率為 1.44，流動比率為 1.44。</p>
<p>阿卡迪亞醫療保健（NASDAQ:ACHC - 獲取免費報告）最近於 11 月 5 日公佈了季度財報。該公司報告本季度每股收益為 0.72 美元，超出市場共識預期的 0.71 美元，超出 0.01 美元。阿卡迪亞醫療保健的股本回報率為 7.66%，淨利潤率為 3.29%。該公司本季度的收入為 8.5157 億美元，而分析師預期為 8.5243 億美元。去年同期，該公司每股收益為 0.91 美元。阿卡迪亞醫療保健的季度收入同比增長了 4.4%。阿卡迪亞醫療保健已將其 2025 財年的指導目標設定為 2.350-2.450 美元每股收益。股票分析師預計阿卡迪亞醫療保健在當前財年將發佈 3.38 美元的每股收益。</p>
<h2>阿卡迪亞醫療保健公司簡介</h2>
<p>（獲取免費報告）</p>
<p>阿卡迪亞醫療保健公司在美國和波多黎各提供行為健康護理服務。該公司開發和運營急性住院精神病設施、包括住宅康復設施和飲食失調設施的專業治療設施、綜合治療中心和住宅治療中心，以及為社區的行為健康和康復需求提供的門診行為健康護理服務設施。</p>
<h2>另請參閲</h2>
<ul>
<li>五隻我們更看好的股票，勝過阿卡迪亞醫療保健</li>
<li>投資者如何識別併成功交易缺口下跌股票</li>
<li>2026 年應避免的三隻最近被下調評級的股票</li>
<li>能源和石油股票解析</li>
<li>芯片熱潮迴歸：三隻有望獲得巨大收益的股票</li>
<li>如何知道一隻股票是否支付股息以及何時支付</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUNIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUNIQw"/></p>
<p><em>此即時新聞提醒由敍述科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在阿卡迪亞醫療保健嗎？</h2>
<p>在你考慮阿卡迪亞醫療保健之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而阿卡迪亞醫療保健並不在名單上。</p>
<p>雖然阿卡迪亞醫療保健目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

阿卡迪亞醫療保健

<p>阿卡迪亞醫療保健（NASDAQ:ACHC）獲得了分析師一致的 “持有” 評級，評級各異，包括賣出、持有和買入。KeyCorp、加拿大皇家銀行、Leerink Partners、瑞銀集團和 Raymond James Financial 調整了價格目標。機構投資者已改變在 ACHC 的持股比例，該股票開盤價為 14.45 美元，市值為 13.3 億美元。阿卡迪亞報告了上個季度每股收益為 0.72 美元，超出預期，並預計本財年的每股收益為 3.38 美元</p>

<p>Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) has been assigned an average recommendation of &#34;Hold&#34; from the sixteen analysts that are presently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and eight have issued a buy rating on the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $23.1667.</p>
<div class="lb-trans"><p>阿卡迪亞醫療保健公司（NASDAQ:ACHC - 獲取免費報告）目前被 16 位分析師給予了 “持有” 的平均推薦，MarketBeat Ratings 報告稱。兩位投資分析師對該股票給予了賣出評級，六位分析師給予了持有評級，八位分析師給予了買入評級。在過去一年中，發佈報告的券商對該股票的平均一年目標價為 23.1667 美元。</p>
</div><p>Get <strong>Acadia Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>阿卡迪亞醫療保健</strong> 的提醒：</p>
</div><ul>
<li>Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?&#34;</li>
</ul>
<div class="lb-trans"><ul>
<li>Neurogene 股票暴跌 44%：這家生物科技公司還有希望嗎？</li>
</ul>
</div><p>Several equities analysts recently issued reports on the company. KeyCorp reduced their price objective on Acadia Healthcare from $30.00 to $25.00 and set an &#34;overweight&#34; rating on the stock in a research note on Wednesday, December 3rd. Royal Bank Of Canada reduced their price target on shares of Acadia Healthcare from $22.00 to $19.00 and set an &#34;outperform&#34; rating on the stock in a research report on Wednesday, December 3rd. Leerink Partnrs downgraded shares of Acadia Healthcare from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Wednesday, December 3rd. UBS Group dropped their price objective on shares of Acadia Healthcare from $28.00 to $24.00 and set a &#34;buy&#34; rating on the stock in a research note on Wednesday, December 3rd. Finally, Raymond James Financial set a $17.00 target price on Acadia Healthcare in a research note on Wednesday, December 3rd.</p>
<div class="lb-trans"><p>幾位股票分析師最近對該公司發佈了報告。KeyCorp 將阿卡迪亞醫療保健的目標價從 30.00 美元下調至 25.00 美元，並在 12 月 3 日的研究報告中給予該股票 “增持” 評級。加拿大皇家銀行將阿卡迪亞醫療保健的目標價從 22.00 美元下調至 19.00 美元，並在 12 月 3 日的研究報告中給予該股票 “跑贏大盤” 評級。Leerink Partners 將阿卡迪亞醫療保健的股票評級從 “強力買入” 下調至 “持有”，該報告於 12 月 3 日發佈。瑞銀集團將阿卡迪亞醫療保健的目標價從 28.00 美元下調至 24.00 美元，並在 12 月 3 日的研究報告中給予該股票 “買入” 評級。最後，Raymond James Financial 在 12 月 3 日的研究報告中設定了阿卡迪亞醫療保健的目標價為 17.00 美元。</p>
</div><p><strong>Read Our Latest Report on ACHC</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 ACHC 的最新報告</strong></p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>A number of institutional investors have recently added to or reduced their stakes in ACHC. Caitong International Asset Management Co. Ltd lifted its stake in Acadia Healthcare by 11,218.2% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock valued at $38,000 after buying an additional 1,234 shares during the last quarter. Allworth Financial LP increased its holdings in shares of Acadia Healthcare by 676.4% in the 2nd quarter. Allworth Financial LP now owns 1,351 shares of the company's stock worth $31,000 after acquiring an additional 1,177 shares during the period. EverSource Wealth Advisors LLC lifted its position in Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company's stock valued at $32,000 after purchasing an additional 497 shares during the last quarter. Hantz Financial Services Inc. boosted its stake in Acadia Healthcare by 501.9% during the 3rd quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company's stock valued at $54,000 after purchasing an additional 1,822 shares during the period. Finally, Covestor Ltd grew its position in Acadia Healthcare by 56.0% in the 1st quarter. Covestor Ltd now owns 2,262 shares of the company's stock worth $69,000 after purchasing an additional 812 shares during the last quarter.</p>
<div class="lb-trans"><p>一些機構投資者最近增加或減少了對 ACHC 的持股。凱通國際資產管理有限公司在第一季度將其在阿卡迪亞醫療保健的持股增加了 11218.2%。凱通國際資產管理有限公司現在擁有 1245 股該公司的股票，價值 38,000 美元，此前在上個季度購買了 1234 股。Allworth Financial LP 在第二季度將其在阿卡迪亞醫療保健的持股增加了 676.4%。Allworth Financial LP 現在擁有 1351 股該公司的股票，價值 31,000 美元，此前在此期間又收購了 1177 股。EverSource Wealth Advisors LLC 在第二季度將其在阿卡迪亞醫療保健的持股增加了 54.8%。EverSource Wealth Advisors LLC 現在擁有 1404 股該公司的股票，價值 32,000 美元，此前在上個季度購買了 497 股。Hantz Financial Services Inc. 在第三季度將其在阿卡迪亞醫療保健的持股增加了 501.9%。Hantz Financial Services Inc. 現在擁有 2185 股該公司的股票，價值 54,000 美元，此前在此期間又購買了 1822 股。最後，Covestor Ltd 在第一季度將其在阿卡迪亞醫療保健的持股增加了 56.0%。Covestor Ltd 現在擁有 2262 股該公司的股票，價值 69,000 美元，此前在上個季度購買了 812 股。</p>
</div><h2>Acadia Healthcare Stock Performance</h2>
<div class="lb-trans"><h2>阿卡迪亞醫療保健股票表現</h2>
</div><p>Shares of ACHC stock opened at $14.45 on Friday. The stock has a market capitalization of $1.33 billion, a price-to-earnings ratio of 12.35, a PEG ratio of 3.24 and a beta of 0.91. Acadia Healthcare has a one year low of $12.63 and a one year high of $47.08. The company's 50-day simple moving average is $19.79 and its 200-day simple moving average is $21.46. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.44 and a current ratio of 1.44.</p>
<div class="lb-trans"><p>ACHC 股票在週五開盤價為 14.45 美元。該股票的市值為 13.3 億美元，市盈率為 12.35，PEG 比率為 3.24，貝塔值為 0.91。阿卡迪亞醫療保健的年內最低價為 12.63 美元，最高價為 47.08 美元。該公司的 50 日簡單移動平均線為 19.79 美元，200 日簡單移動平均線為 21.46 美元。該公司的債務與股本比率為 0.73，速動比率為 1.44，流動比率為 1.44。</p>
</div><p>Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings data on Wednesday, November 5th. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.01. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.The firm had revenue of $851.57 million during the quarter, compared to analyst estimates of $852.43 million. During the same period in the previous year, the company earned $0.91 earnings per share. Acadia Healthcare's quarterly revenue was up 4.4% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Equities analysts anticipate that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>阿卡迪亞醫療保健（NASDAQ:ACHC - 獲取免費報告）最近於 11 月 5 日公佈了季度財報。該公司報告本季度每股收益為 0.72 美元，超出市場共識預期的 0.71 美元，超出 0.01 美元。阿卡迪亞醫療保健的股本回報率為 7.66%，淨利潤率為 3.29%。該公司本季度的收入為 8.5157 億美元，而分析師預期為 8.5243 億美元。去年同期，該公司每股收益為 0.91 美元。阿卡迪亞醫療保健的季度收入同比增長了 4.4%。阿卡迪亞醫療保健已將其 2025 財年的指導目標設定為 2.350-2.450 美元每股收益。股票分析師預計阿卡迪亞醫療保健在當前財年將發佈 3.38 美元的每股收益。</p>
</div><h2>Acadia Healthcare Company Profile</h2>
<div class="lb-trans"><h2>阿卡迪亞醫療保健公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.</p>
<div class="lb-trans"><p>阿卡迪亞醫療保健公司在美國和波多黎各提供行為健康護理服務。該公司開發和運營急性住院精神病設施、包括住宅康復設施和飲食失調設施的專業治療設施、綜合治療中心和住宅治療中心，以及為社區的行為健康和康復需求提供的門診行為健康護理服務設施。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另請參閲</h2>
</div><ul>
<li>Five stocks we like better than Acadia Healthcare</li>
<li>How Investors Can Identify and Successfully Trade Gap-Down Stocks</li>
<li>3 Recently Downgraded Stocks to Avoid in 2026</li>
<li>Energy and Oil Stocks Explained</li>
<li>The Chip Boom Is Back: 3 Stocks Positioned for Huge Gains</li>
<li>How to Know if a Stock Pays Dividends and When They Are Paid Out</li>
<li>Oracle Stock Hit Hard: Why Its AI Pipeline Could Drive a 2026 Rally</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過阿卡迪亞醫療保健</li>
<li>投資者如何識別併成功交易缺口下跌股票</li>
<li>2026 年應避免的三隻最近被下調評級的股票</li>
<li>能源和石油股票解析</li>
<li>芯片熱潮迴歸：三隻有望獲得巨大收益的股票</li>
<li>如何知道一隻股票是否支付股息以及何時支付</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUNIQw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=ACHC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Acadia Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在阿卡迪亞醫療保健嗎？</h2>
</div><p>Before you consider Acadia Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮阿卡迪亞醫療保健之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而阿卡迪亞醫療保健並不在名單上。</p>
</div><p>While Acadia Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然阿卡迪亞醫療保健目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

阿卡迪亞醫療保健公司（NASDAQ:ACHC）獲得分析師一致推薦 “持有” 評級